skip to the main content

Free Anti-Infliximab

Detecting free antibodies to infliximab for personalized treatment

AFIAS Free Anti-Infliximab detects the amount of free anti-infliximab antibodies in the blood. This is very helpful for clinicians to monitor patient’s condition and optimize the appropriate therapeutic regimen.

Diagnosis diseases
Anti-infliximab antibody in the human body, Antibody to Infliximab (ATI)

Available Instruments

About Using Reagent

  • Sample Types

    Whole blood, Serum, Plasma
  • Reaction Time

    12 mins
  • Detection Range

    4-250 AU/mL
  • Indication

    Anti-drug antibody (ADA) monitoring, Immunogenicity screening

In Your Medical Field

AFIAS Free Anti-Infliximab detects antibodies to infliximab within 12 minutes in a small amount of blood. It enables users to check the patient's condition immediately prior to administration and to prescribe the optimal dosage of the drug depending on each of patient’s treatment plan. It also can minimize side effects in advance. Ultimately, it can help patients get the best therapy.